Patent ID: 6683100
Filing Date: 2004-01-27
Classification: A61K

Abstract:
A pharmaceutical formulation in the form of an infusion concentrate for treating a proliferative disease sensitive to an epothilone comprising the epothilone dissolved in a pharmaceutically acceptable organic solvent selected from the group consisting of ethanol, a mixture of ethanol and water, wherein the volume to volume ratio of ethanol to water ratio is in the range from almost about 100:0 to about 10:90, propylene glycol, propylene glycol 300, polyethylene glycol 400, and a mixture of propylene glycol, polyethylene glycol 300 or polyethylene glycol 400 with water, wherein the volume to volume ratio of propylene glycol, polyethylene glycol 300 or polyethylene glycol 400 to water is in the range from about 100:0 to almost about 30:70.